A DIFFERENT WAY TO EXPLORE

Similar work.
More providers to explore.

Compare the published Medicare service mix of Ronald Lee Leonard, D.O. with clinicians in the same registry specialty: Pathology (CMS).

KS · Exact areaEdit location

2024 published service data · 100 eligible profiles compared. Similarity describes billing patterns, not quality, outcomes, or suitability for your care.

Susan L. Speaks, M.D.

Pathology (CMS) · Manhattan, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
58%Service-mix similarityView profile →

Brett William Sramek, DO

Pathology (CMS) · Lenexa, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
53%Service-mix similarityView profile →

Dionnee James, MD

Pathology (CMS) · Manhattan, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
50%Service-mix similarityView profile →

Aaron Paul Rupp

Pathology (CMS) · Lenexa, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Cell examination of specimen, selective cellular enhancement technique (88112)
49%Service-mix similarityView profile →

Fangyuan Fred Zhang, M.D.

Pathology (CMS) · Wichita, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (87624)
48%Service-mix similarityView profile →

Pablo J Hernandez-Rios, MD

Pathology (CMS) · Lenexa, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Cell examination of specimen, selective cellular enhancement technique (88112)
47%Service-mix similarityView profile →

Julie A Moore, MD

Pathology (CMS) · Salina, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (G0476)
  • Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (87624)
46%Service-mix similarityView profile →

Ossama W Tawfik, M.D.,PHD

Pathology (CMS) · Lenexa, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Cell examination of specimen, selective cellular enhancement technique (88112)
45%Service-mix similarityView profile →

Bradley Carmichael, M.D.

Pathology (CMS) · Lenexa, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Cell examination of specimen, selective cellular enhancement technique (88112)
44%Service-mix similarityView profile →

Natalie M Webster, MD

Pathology (CMS) · Lenexa, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (G0145)
  • Cell examination of specimen, selective cellular enhancement technique (88112)
44%Service-mix similarityView profile →

Anirudha Halder, MD

Pathology (CMS) · Manhattan, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Cell examination of specimen, selective cellular enhancement technique (88112)
  • Pathology examination of tissue using a microscope, moderately low complexity (88304)
43%Service-mix similarityView profile →

Le Wen Liu, MD PHD

Pathology (CMS) · Wichita, KS

Shared published services
3 shared services · view billing descriptions
  • Pathology examination of tissue using a microscope, intermediate complexity (88305)
  • Cell examination of specimen, selective cellular enhancement technique (88112)
  • Pathology examination of tissue using a microscope, moderately low complexity (88304)
41%Service-mix similarityView profile →
How this comparison works

We use the same calendar year of CMS Medicare Physician & Other Practitioners data for both providers. Published non-drug service counts are combined by HCPCS code across places of service. We apply log(1 + count), normalize the vectors, and compare them using cosine similarity.

Candidates share the reference provider’s current NPPES primary taxonomy and match the location you enter. We examine up to 500 candidates in NPI order, then show up to 12 with the highest positive similarity within that set. The score is not a percentile, medical recommendation, or prediction. Suppressed services are not estimated. Medicare fee-for-service data does not describe a provider’s entire practice.

Source: CMS Medicare Physician & Other Practitioners - by Provider and Service : 2024-12-01 · Published May 21, 2026.